<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Izotropic Corp. — News on 6ix</title>
<link>https://6ix.com/company/izotropic-corporation</link>
<description>Latest news and press releases for Izotropic Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/izotropic-corporation" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836833478dffbe2df16931f.webp</url>
<title>Izotropic Corp.</title>
<link>https://6ix.com/company/izotropic-corporation</link>
</image>
<item>
<title>Izotropic Africa Launches Operations in Casablanca</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-africa-launches-operations-in-casablanca</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-africa-launches-operations-in-casablanca</guid>
<pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
<description>Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - April 29, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the official launch of Izotropic Africa in Casablanca, Morocco, and the appointment of Mr. Mohammed Sair as General Manager. Advancing Regional Operations...</description>
</item>
<item>
<title>Izotropic Announces Debt Settlement</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-announces-debt-settlement</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-announces-debt-settlement</guid>
<pubDate>Tue, 21 Apr 2026 18:09:00 GMT</pubDate>
<description>Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 21, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has entered into a debt settlement agreement (the "Agreement") with a lender (the "Lender") to settle a portion of the.</description>
</item>
<item>
<title>Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropics-izotropic-africa-enters-partnership-discussions-with-the-mohammed-vi-foundation-for-science-and-health</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropics-izotropic-africa-enters-partnership-discussions-with-the-mohammed-vi-foundation-for-science-and-health</guid>
<pubDate>Wed, 25 Feb 2026 13:00:00 GMT</pubDate>
<description>Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - February 25, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that, further to its February 18th announcement regarding the formation "Izotropic Africa" under a Letter Agreement, the...</description>
</item>
<item>
<title>Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-signs-letter-agreement-for-regional-operations-in-africa-and-the-gcc</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-signs-letter-agreement-for-regional-operations-in-africa-and-the-gcc</guid>
<pubDate>Wed, 18 Feb 2026 13:00:00 GMT</pubDate>
<description>Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 18, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has entered into a Letter Agreement (the "Agreement") with a business group ("BG") to establish an entity named...</description>
</item>
<item>
<title>Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-closes-non-brokered-private-130000317</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-closes-non-brokered-private-130000317</guid>
<pubDate>Wed, 04 Feb 2026 13:00:00 GMT</pubDate>
<description>Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 4, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that further to its January 28, 2026 announcement it has completed a non-brokered private placement financing (the...</description>
</item>
<item>
<title>Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-provides-corporate-announces-non-130000341</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-provides-corporate-announces-non-130000341</guid>
<pubDate>Wed, 28 Jan 2026 13:00:00 GMT</pubDate>
<description>Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - January 28, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, provides a corporate update and announces the intention to complete a small non-brokered private placement financing. The Company's...</description>
</item>
<item>
<title>Izotropic Announces AGM Results</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-announces-agm-results-213100263</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-announces-agm-results-213100263</guid>
<pubDate>Wed, 31 Dec 2025 21:31:00 GMT</pubDate>
<description>Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - December 31, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the results of its Annual General and Special Meeting held on December 29, 2025. Company matters submitted to shareholders..</description>
</item>
<item>
<title>Izotropic Launches Podcast Episode #2: AI and the Future of Breast Imaging: How Izotropic is Leading the Innovation</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-launches-podcast-episode-2-130000705</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-launches-podcast-episode-2-130000705</guid>
<pubDate>Wed, 12 Nov 2025 13:00:00 GMT</pubDate>
<description>Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - November 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the release of the second episode in its podcast series: AI and the Future of Breast Imaging: How Izotropic is Leading the.</description>
</item>
<item>
<title>Izotropic Launches "Breast Imaging News" Page on BreastCT.com</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-launches-breast-imaging-news-120000699</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-launches-breast-imaging-news-120000699</guid>
<pubDate>Tue, 28 Oct 2025 12:00:00 GMT</pubDate>
<description>Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce the launch of the "Breast Imaging News" section on BreastCT.com - a timely and strategic addition to the...</description>
</item>
<item>
<title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-corporations-cse-izo-otcqb-izozf-leverages-ai-with-next-gen-breast-ct-imaging-system</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-corporations-cse-izo-otcqb-izozf-leverages-ai-with-next-gen-breast-ct-imaging-system</guid>
<pubDate>Fri, 24 Oct 2025 14:50:00 GMT</pubDate>
<description>NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Investors Turn to AI-Driven Imaging</description>
</item>
<item>
<title>Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-ceo-interview-izoview-differentiators-120000736</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-ceo-interview-izoview-differentiators-120000736</guid>
<pubDate>Thu, 23 Oct 2025 12:00:00 GMT</pubDate>
<description>Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the release of a new video interview with the Company's CEO in partnership with Departures Capital. The interview delves...</description>
</item>
<item>
<title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-corporation-cse-izo-otcqb-izozf-stands-out-with-proprietary-next-gen-breast-ct-imaging-system</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-corporation-cse-izo-otcqb-izozf-stands-out-with-proprietary-next-gen-breast-ct-imaging-system</guid>
<pubDate>Wed, 22 Oct 2025 12:30:00 GMT</pubDate>
<description>NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging</description>
</item>
<item>
<title>Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-marks-breast-cancer-awareness-120000623</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-marks-breast-cancer-awareness-120000623</guid>
<pubDate>Wed, 08 Oct 2025 12:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, and SACRAMENTO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, marks Breast Cancer Awareness Month by underscoring the persistent limitations in current breast cancer imaging tools and the signif</description>
</item>
<item>
<title>AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge</title>
<link>https://6ix.com/company/izotropic-corporation/news/ai-breast-imaging-breastct-com-120000921</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/ai-breast-imaging-breastct-com-120000921</guid>
<pubDate>Thu, 25 Sep 2025 12:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce the publication of a new feature article on BreastCT.com titled “AI Is Reshaping Breast Imaging, and IzoView</description>
</item>
<item>
<title>Izotropic’s IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-izoview-breast-ct-first-120000521</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-izoview-breast-ct-first-120000521</guid>
<pubDate>Tue, 23 Sep 2025 12:00:00 GMT</pubDate>
<description>- Patent-pending pre-scan technology enables custom radiation dose tailored to patient’s unique breast size and composition - - Feature aligns with personalized medicine trends driving the global breast imaging device market size to USD $8.69 billion by 2030 - - Integrated into the IzoView commercial model alongside modular engineering, compression-free imaging, and AI-driven image optimization - VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN – Iz</description>
</item>
<item>
<title>Izotropic Closes Non-Brokered Private Placement and Engages Awareness Consultants</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-closes-non-brokered-private-120000880</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-closes-non-brokered-private-120000880</guid>
<pubDate>Fri, 19 Sep 2025 12:00:00 GMT</pubDate>
<description>Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that further to its August 26th announcement it has completed a non-brokered private placement financing (the "Offering"),.</description>
</item>
<item>
<title>Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-publishes-faq-page-investors-120000452</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-publishes-faq-page-investors-120000452</guid>
<pubDate>Tue, 16 Sep 2025 12:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of a new Frequently Asked Questions (“FAQ”) page on its corporate website. The new FAQ resource, available at w</description>
</item>
<item>
<title>Izotropic Gains Visibility as AI Market Broadens Beyond Tech</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-gains-visibility-ai-market-172400982</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-gains-visibility-ai-market-172400982</guid>
<pubDate>Wed, 10 Sep 2025 17:24:00 GMT</pubDate>
<description>Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 10, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces its sponsored placement in an editorial published on MarketScreener.com. To view the full publication, "From Healthcare to.</description>
</item>
<item>
<title>Izotropic Secures Exclusive Rights to Patented Computer-Aided Diagnosis for Breast CT</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-secures-exclusive-rights-patented-120000986</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-secures-exclusive-rights-patented-120000986</guid>
<pubDate>Wed, 03 Sep 2025 12:00:00 GMT</pubDate>
<description>- U.S. patent protection covers computer-aided diagnosis (“CADx”) with breast CT - - Izotropic holds the exclusive rights to this patent and breast CT technology under global license agreement - - CADx upgrade to be integrated into IzoView Breast CT post-initial market launch, feature may be offered as an upgrade incentive to early adopters - VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3</description>
</item>
<item>
<title>Izotropic’s AI Breakthrough Positions IzoView to Redefine Breast CT Imaging Standards</title>
<link>https://6ix.com/company/izotropic-corporation/news/izotropic-ai-breakthrough-positions-izoview-120000813</link>
<guid isPermaLink="true">https://6ix.com/company/izotropic-corporation/news/izotropic-ai-breakthrough-positions-izoview-120000813</guid>
<pubDate>Thu, 28 Aug 2025 12:00:00 GMT</pubDate>
<description>- Proprietary algorithm positions IzoView to redefine global standards and expectations for image quality and safety in breast CT - - Trained on 15 years of specialized breast CT data and protected as a trade secret, giving Izotropic a durable competitive edge - - AI enhances IzoView’s image quality by reducing CT image noise without increasing radiation dose - VANCOUVER, British Columbia, and SACRAMENTO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB</description>
</item>
</channel>
</rss>